For more information or confidential assistance
Call 800-306-3180

FDA Releases New Safety Communication Regarding Invokana

One of the newer generations of diabetes medications, Invokana, has come under fire in recent months for potentially increasing the risk of serious health problems. Now, the FDA has issued a new safety communication informing healthcare practitioners and patients that the agency has revised labeling information... Read More